Filter
73
Text search:
multisystem
inflammatory
syndrome
Featured
Recommendations
19
New Publications
3
Language
Document type
Guidelines
42
Fact sheets
11
Manuals
8
Studies & Reports
4
No document type
4
Training Material
2
Strategic & Response Plan
2
Countries / Regions
Brazil
8
Germany
5
India
4
Russia
4
Nigeria
2
Syria
2
Rwanda
2
Mozambique
2
Yemen
2
Middle East and North Africa
2
Western and Central Europe
2
Sierra Leone
1
Liberia
1
Uganda
1
South Sudan
1
South Africa
1
Malawi
1
Argentina
1
Ukraine
1
Colombia
1
East and Southern Africa
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Africa
1
Authors & Publishers
Publication Years
Category
Countries
31
Clinical Guidelines
5
Women & Child Health
1
Toolboxes
COVID-19
64
Ebola
2
Caregiver
2
Conflict
1
Rapid Response
1
Refugee
1
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
first issued 18 August 2022
Archives of Disease in Childhood 2021;106:238-240.
In Deutschland leben ca. 200.000 Geflüchtete in Aufnahmeeinrichtungen und Gemeinschaftsunterkünften (Stand:31.12.2018). Massnahmen der physischen Distanzierung sind in der Sammelunterbringung für Geflüchtete meist nicht oder nur bedingt umsetzbar: Beengte Verhältnisse, Mehrbettzimmer und gemein
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Critical preparedness, readiness and response actions for COVID-19
Interim Guidance - 27 May 2021
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc
...
